Analytical Data
-
Gene name
Enho
- Application
-
Alternative Names
(Energy homeostasis-associated protein)
-
Species
Mouse
-
Source
E. coli
-
Tag
N- His-KSI
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8K1D8
-
Expression Region
34-76aa
-
Molecular Weight
19.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Enho, or Endothelin-Hormones and other Proteins, is a significant focus of research due to its potential implications in various physiological and pathological processes. Initially isolated from endothelial cells, Enho proteins are primarily involved in cardiovascular regulation, cell proliferation, and apoptosis, making them crucial in understanding diseases such as hypertension, heart failure, and cancer. Recent studies have highlighted the role of Enho in modulating neural and endocrine functions, as well as its involvement in inflammatory responses. Given the complexity of its interactions and mechanisms, the recombinant production of Enho proteins has gained traction in biotechnological research. Researchers aim to produce these proteins in controlled environments to facilitate in-depth analyses of their biological functions, structure-function relationships, and therapeutic potentials. Generating recombinant Enho proteins allows for the study of their signaling pathways and interactions with other biomolecules, laying the groundwork for novel therapeutic strategies. Furthermore, understanding the structure of Enho could unlock possibilities for developing targeted drugs that can intervene in its signaling pathways. As the field progresses, the elucidation of Enho functions may lead to breakthroughs in understanding and treating a range of conditions, ultimately contributing to personalized medicine and improved health outcomes. The ongoing research into recombinant Enho proteins represents a promising frontier in biomedical science, aiming to harness the potential of these molecules for therapeutic applications.
